NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
04/23/2024
Back to search
Official data from USPTO
INTELLISELECT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
INTELLISELECT
ST13
US500000097040176Class
5, 9, 42, 44
Filing
97040176
Registration
7058471
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
04/23/2024
Classification
Registered
Trademark type
Word
Nice classes
5, 9, 42, 44
Filing date
09/22/2021
Registration date
05/23/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/23/2023
Last transaction
03/18/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Cambridge, GB
Examiner
AGOSTO, GISELLE MARIE
Law office
O30
Current location
TMO LAW OFFICE 130
Holders and representatives
Holders
Kymab Limited
Representatives
Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention of diseases and disorders caused by bacteria; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the prevention of diseases of the immune system; preparations for detecting genetic predispositions for medical purposes; chemical preparations for medical use in DNA analysis; medicines for treating bacterial diseases and disorderscancerimmune-system diseases and disorders; vaccines; human vaccine preparations; vaccines for human use
Class 9
Downloadable computer software for use in scientific and pharmaceutical research and development for identifyingcreating or selecting antibody or antigen binding fragment thereofsequences and nucleic acids encoding them; downloadable computer software for scientific modelling antibodies and antigen binding fragment thereof; downloadable computer software for pharmaceutical modelling; downloadable computer software for research and development in the field of antibodies discovery
Class 42
Research and development services in the medical and pharmaceuticals field of medicinesgeneticsantibodiesoncologyimmunology and inflammatory diseases and disorders; design and development of computer hardware and software; clinical research in the field of antibodiesoncologyimmunology and inflammatory diseases and disorders; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; structural and functional analysis of genomes; drug discovery services; laboratory research services relating to pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; biotechnology testing and research to discover antibodies and pharmaceutical substances ; research in the field of medicines; research and development of vaccines and medicines; providing medical and scientific research information in the field of pharmaceuticals; medical research services; providing information in medical research concerning pharmaceutical substances
Class 44
Medical diagnostic testingmonitoring and reporting services; DNA screening for medical purposes; genetic analysis and reporting services for medical purposes in relation to the treatment of persons; medical services relating to DNAgenetics and genetic testing; genetic counselling
Publications
History of USPTO decisions and trademark events.
23 publications found
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
03/15/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/11/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
07/18/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/23/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/23/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/07/2023
PUBO
PUBLISHED FOR OPPOSITION
03/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/26/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/21/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/21/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/23/2022
GNRT
NON-FINAL ACTION E-MAILED
06/23/2022
CNRT
NON-FINAL ACTION WRITTEN
06/23/2022
DOCK
ASSIGNED TO EXAMINER
06/23/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/28/2021
ALIE
ASSIGNED TO LIE
10/28/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/25/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/05/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/04/2021
NWAP
NEW APPLICATION ENTERED
09/25/2021
Continuous trademark protection
Get notified about every new filing that threatens INTELLISELECT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.